The Clinical Policies Committee and...

The Clinical Policies Committee and the Clinical Policies Subcommittee forward Suspected Pulmonary Embolism of the American society of Emergency Physicians (ACEP) lately released a clinical policy focusing onward critical issues in the evaluation and management of patients with signs and symptoms of pulmonary embolism (PE) The clinical policy was published in the February 2003 issue of Annals of push Medicine. This policy is a revision of the 1995 ACEP chest pain policy as related to the initial approach to patients with signs and symptoms of PE that was published in the February 1995 issue of Annals of crisis Medicine.

Strength of Recommendations

The authors of these guidelines provide recommendations for management of PE based forward strength of evidence. Level A recommendations are generally accepted management principles that cogitate a high degree of clinical certainty. flush B recommendations are management strategies that cast reproach a moderate clinical certainty. plain C recommendations are management strategies based in succession preliminary, inconclusive, or conflicting evidence or, in the absence of any published literature, based onward panel consensus.

Diagnostic Usefulness of d-dimer

As a terminate of fibrinolysis, d-dimers are released and are an indicator of the neighborhood of endovascular thrombus. The five major emblems of d-dimer assays are enzyme-linked immunosorbent assay (ELISA), latex agglutination assay, whole children assay, turbidimetric assay, and immunofiltration assay. According to the ACEP policy, the sensitivity of the ELISA d-dimer for the diagnosis of PE is 97 percent and the specificity is 44 percent However, ELISA assays require couple to four hours to thorough Latex assays are more rapid, on the contrary produce inadequate sensitivity to eliminate PE A whole life-current assay has a pooled sensitivity of 89 percent and specificity of 59 percent for the detection of PE It solely requires five minutes to perform and reliably not includes PE when used with the Wells' scoring order for estimating pretest probability of PE (see table). The rapid ELISA and turbidimetric assays provide at least a 95 percent sensitivity for the detection of PE

flat A recommendations: None specified.

even B recommendations: In patients with a gentle pretest probability of PE, use the following ordeals to exclude PE:

1 A negative quantitative d-dimer assay (turbidimetric or ELISA).

2 A negative whole kin cell qualitative d-dimer assay in conjunction with a Wells' score of 2 or less

of the same height C recommendations: In patients with a gentle pretest probability of PE, negative findings in succession a whole blood d-dimer assay (when not used with Wells' scoring system) or immunofiltration d-dimer assay can be used to omit PE.

Diagnostic Usefulness of Ventilation/Perfusion Scan

The radioisotopic ventilation/perfusion (V/Q) scan has been the greatest in quantity widely accepted screening test for PE in the difficulty department for two decades. According to the ACEP policy, if the pretest probability is les than 20 percent and the patient has a "near normal/normal" V/Q scan, PE can be exclud with reasonable certainty. In patients with a pretest probability of 20 percent or higher, a "high probability" V/Q scan can be used to diagnose PE with reasonable certainty.

A general practice in patients with nondiagnostic V/Q scans is to obtain duplex ultrasonography of the lower extremities, because discerning venous thrombosis is present in a significant number of patients with confirmed PE Also, a negative ultrasonographic scan significantly lowers the probability of PE in these patients. However, this negative finding should not be used to except PE in patients with a non-low pretest probability and a nondiagnostic V/Q scan.

plain A recommendations: In patients with a low-to-moderate pretest probability of PE a normal perfusion scan reliably prohibits clinically significant PE.

on a level B recommendations: In patients with a low-to-moderate pretest probability of PE and a nondiagnostic V/Q scan, use single of the following tests instead of pulmonary arteriography to reject clinically significant PE:

1 A negative quantitative d-dimer assay (turbidimetric or ELISA)

2 A negative whole posterity cell qualitative d-dimer assay in conjunction with a Wells' score of 4 or less

3 A negative single bilateral venous ultrasonographic scan for low-probability patients.

4 A negative serial bilateral venous ultrasonographic scan for moderate-probability patients.

on a level C recommendations: In patients with a low-to-moderate pretest probability of PE and a nondiagnostic V/Q scan, use a negative whole offspring d-dimer assay (when not used with Wells' scoring system) or immunofiltration d-dimer assay to prohibit PE.

Diagnostic Usefulness of Spiral Comput Tomography

The spiral comput tomographic (CT) angiogram is useful for evaluating patients for PE who have conditions that issue in nondiagnostic V/Q scans. According to the ACEP policy, the diagnostic sensitivity of spiral CT is at least 95 percent for segmental or larger PE and approximately 75 percent for subsegmental PE A negative finding in succession a CT scan reliably restrains clinically significant PE.